Xingxin Xu
- Molecular Biology
- Nephrology top 5%
- Immunology
- Cancer Research
- Endocrinology, Diabetes and Metabolism
- Topics
- Immune cells in cancer (7 papers)Chronic Kidney Disease and Diabetes (5 papers)Advanced Glycation End Products research (5 papers)
- Partner nations
- China
In The Last Decade
Xingxin Xu
22 papers receiving 465 citations
Peers
Comparison fields: 5 of 86
- Molecular Biology 177
- Nephrology 163
- Immunology 109
- Cancer Research 61
- Endocrinology, Diabetes and Metabolism 46
Countries citing papers authored by Xingxin Xu
This map shows the geographic impact of Xingxin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingxin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingxin Xu more than expected).
Fields of papers citing papers by Xingxin Xu
This network shows the impact of papers produced by Xingxin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingxin Xu. The network helps show where Xingxin Xu may publish in the future.
Co-authorship network of co-authors of Xingxin Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Xingxin Xu. A scholar is included among the top collaborators of Xingxin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingxin Xu. Xingxin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 3 | |
| 3 | 2 | |
| 4 | 10 | |
| 5 | 5 | |
| 6 | 1 | |
| 7 | 33 | |
| 8 | 1 | |
| 9 | 5 | |
| 10 | 83 | |
| 11 | 16 | |
| 12 | 12 | |
| 13 | 37 | |
| 14 | 10 | |
| 15 | 28 | |
| 16 | 30 | |
| 17 | 16 | |
| 18 | 30 | |
| 19 | 28 | |
| 20 | 36 |
About Xingxin Xu
Xingxin Xu is a scholar working on Nephrology, Clinical Biochemistry and Immunology, having authored 23 papers that have together received 470 indexed citations. Recurring topics across this work include Immune cells in cancer (7 papers), Chronic Kidney Disease and Diabetes (5 papers) and Advanced Glycation End Products research (5 papers). The work is most often cited by research in Nephrology (163 citations), Clinical Biochemistry (44 citations) and Immunology (109 citations). Xingxin Xu has collaborated with scholars based in China. Frequent co-authors include Yonggui Wu, Xiangming Qi, Xuerong Wang, Xiao‐Ming Meng, Mei Zhu, Kun Wang, Jijia Shen, Zhe Fan, Han-xu Zeng and Hualiang Huang. Their work appears in journals such as The FASEB Journal, Applied Thermal Engineering and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.